within Pharmacolibrary.Drugs.ATC.G;

model G03EK01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.0004166666666666667,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0011,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0038333333333333336,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03EK01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Methyltestosterone is a synthetic orally active androgen, used historically in the treatment of male hypogonadism, certain breast cancers, and menopausal symptoms. Its clinical use has declined in many countries due to safety concerns, including hepatotoxicity, and it is not widely approved for use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult males, based on limited published pharmacokinetic studies and secondary reviews.</p><h4>References</h4><ol><li><p>Vick, AM, &amp; Hayton, WL (2001). Methyltestosterone pharmacokinetics and oral bioavailability in rainbow trout (Oncorhynchus mykiss). <i>Aquatic toxicology (Amsterdam, Netherlands)</i> 52(3-4) 177–188. DOI:<a href=\"https://doi.org/10.1016/s0166-445x(00)00146-6\">10.1016/s0166-445x(00)00146-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11239680/\">https://pubmed.ncbi.nlm.nih.gov/11239680</a></p></li><li><p>Sacchetin, PS, et al., &amp; Moraes, ÂM (2016). Properties of PLA/PCL particles as vehicles for oral delivery of the androgen hormone 17α-methyltestosterone. <i>Materials science &amp; engineering. C, Materials for biological applications</i> 58 870–881. DOI:<a href=\"https://doi.org/10.1016/j.msec.2015.09.071\">10.1016/j.msec.2015.09.071</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26478382/\">https://pubmed.ncbi.nlm.nih.gov/26478382</a></p></li><li><p>Yee, GC, &amp; McGuire, TR (1990). Pharmacokinetic drug interactions with cyclosporin (Part I). <i>Clinical pharmacokinetics</i> 19(4) 319–332. DOI:<a href=\"https://doi.org/10.2165/00003088-199019040-00004\">10.2165/00003088-199019040-00004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2208899/\">https://pubmed.ncbi.nlm.nih.gov/2208899</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03EK01;
